David Langleben

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Robyn J. Barst, Lewis J. Rubin, Walker Long et al. · New England Journal of Medicine · 1996 · 2.7K citations · Full text

Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension

Adel Giaid, Masashi Yanagisawa, David Langleben et al. · New England Journal of Medicine · 1993 · 1.8K citations · Full text

Riociguat for the Treatment of Pulmonary Arterial Hypertension

Hossein Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger et al. · New England Journal of Medicine · 2013 · 1.3K citations · Full text

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

David B. Badesch, Victor F. Tapson, Michael D. McGoon et al. · Annals of Internal Medicine · 2000 · 1.1K citations

Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?

Robert D. Levy, Peter Černáček, David Langleben · Annals of Internal Medicine · 1991 · 977 citations